Literature DB >> 2281340

Update of hepatotoxicity due to classes of drugs in common clinical use: non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents.

H J Zimmerman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2281340     DOI: 10.1055/s-2008-1040488

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  9 in total

1.  COX-2 inhibitor (nimesulide) induced acute liver failure.

Authors:  Sylvia Stadlmann; Heinz Zoller; Wolfgang Vogel; Felix A Offner
Journal:  Virchows Arch       Date:  2002-02-23       Impact factor: 4.064

Review 2.  Idiosyncratic drug reactions: a mechanistic evaluation of risk factors.

Authors:  B K Park; M Pirmohamed; N R Kitteringham
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

Review 3.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 4.  How well tolerated are lipid-lowering drugs?

Authors:  B Tomlinson; P Chan; W Lan
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

5.  Tolvaptan-induced Liver Injury: Who is at Risk? A Case Report and Literature Review.

Authors:  Muhammad Y Khan; Muhammad Shabbir Rawala; Maryam Siddiqui; Waqas Abid; Aysha Aslam
Journal:  Cureus       Date:  2019-06-05

Review 6.  Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention.

Authors:  A V Manoukian; J L Carson
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

Review 7.  Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety.

Authors:  Nicholas Moore
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 8.  Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence.

Authors:  J L Carson; L R Willett
Journal:  Drugs       Date:  1993       Impact factor: 9.546

9.  Characterization of the acyl-adenylate linked metabolite of mefenamic Acid.

Authors:  Howard Horng; Leslie Z Benet
Journal:  Chem Res Toxicol       Date:  2013-02-26       Impact factor: 3.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.